Search | TVST | ARVO Journals

tvst

Issues
Topics
For Authors
About
- Editorial Board

Journals Home

MANAGE ALERTS

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

To View More...

Purchase this article with an account.

or

Subscribe Now

Issues
Topics
For Authors
About
- Editorial Board

Narrow View

NARROW

Content Type

Meeting Abstract (4)
Journal Articles (1)

Journal

Investigative Ophthalmology & Visual Science (4)
Translational Vision Science & Technology (1)

Article Type

ARVO Annual Meeting Abstract (4)
Articles (1)

Topics

Eye Anatomy and Disorders (1)
Translational Research (1)
Vitreous Disorders (1)

Tags

angiogenesis inhibitors (1)
diabetes mellitus (1)
hyperprolactinemia (1)
placebos (1)
prolactin (1)
proliferative diabetic retinopathy (1)
vitreous body (1)

Specify Date Range

From: To: Apply

Showing 1 – 5 of 5

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2023

Levosulpiride for the treatment of diabetic macular edema: A phase 2, randomized, pilot clinical trial

Mariana Edith López Hernánez; Maria Del Carmen Clapp; Carlos Nuñez; Elva Adán- Castro; Renata García; Marlon García Roa; Juan Fernando Rubio Mijangos; Jorge Sánchez; Gabriela Ramírez Hernández; Nundehui Diaz Lezama; Ellery López Star; Thomas Bertsch; Gonzálo Martínez de la Escalera; Jakob Triebel; Nayeli Piñeiro; Monserrat Siqueiros

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2657.

Articles August 2020

Levosulpiride Increases the Levels of Prolactin and Antiangiogenic Vasoinhibin in the Vitreous of Patients with Proliferative Diabetic Retinopathy

PDF

Carlos D. Nuñez-Amaro; Aura Ileana Moreno-Vega; Elva Adan-Castro; Magdalena Zamora; Renata Garcia-Franco; Paulina Ramirez-Neria; Marlon Garcia-Roa; Yolanda Villalpando; Juan Pablo Robles; Gabriela Ramirez-Hernandez; Mariana Lopez; Jorge Sanchez; Ellery Lopez-Star; Thomas Bertsch; Gonzalo Martinez de la Escalera; Ma. Ludivina Robles-Osorio; Jakob Triebel; Carmen Clapp
TAGS: angiogenesis inhibitors, diabetes mellitus, prolactin, vitreous body, proliferative diabetic retinopathy, hyperprolactinemia, placebos
Trans. Vis. Sci. Tech.. 2020; 9(9):27. https://doi.org/10.1167/tvst.9.9.27

ARVO Annual Meeting Abstract June 2020

Prolactin improves retinal function in streptozotocin-induced diabetes

Lourdes Montserrat SIQUEIROS; Elva Hortencia Adan Castro; Francisco Freinet Núñez; Gabriela Ramirez-Hernandez; Daniela Granados-Carrasco; Xarubeth Ruiz-Herrera; Gonzálo Martínez de la Escalera; Carmen Clapp

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):280.

ARVO Annual Meeting Abstract June 2020

Sulpiride increases intraocular vasoinhibin and protects against diabetic retinopathy in rats

Elva Hortencia Adan Castro; Gabriela Ramirez-Hernandez; Nundehui Diaz-Lezama; Lourdes Montserrat SIQUEIROS; Daniela Granados-Carrasco; Xarubeth Ruiz-Herrera; Fernando Lopez-Barrera; Ludivina Robles-Osorio; Gonzálo Martínez de la Escalera; Carmen Clapp

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1881.

ARVO Annual Meeting Abstract June 2020

The prolactin/vasoinhibin axis regulates early postnatal retinal vascularization

Francisco Freinet Núñez; Lourdes Montserrat SIQUEIROS; Miguel Vázquez-Membrillo; Elva Hortencia Adan Castro; Gabriela Ramirez-Hernandez; Gonzálo Martínez de la Escalera; Carmen Clapp

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4958.

« Previous

Advertisement

Follow @ARVOtvst

TVST Home
Issues
Topics
For Authors

About
- Editorial Board

Online ISSN: 2164-2591

Investigative Ophthalmology & Visual Science
Journal of Vision
Translational Vision Science & Technology

JOURNALS HOME
TOPICS
ABOUT ARVO JOURNALS

Copyright © 2025 Association for Research in Vision and Ophthalmology.

Access Provided By:
MIT Libraries

Forgot password?

To View More...

Purchase this article with an account.

Create an Account

or

Subscribe Now

×

×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept